Kwikheal Tablet contains Trypsin Chymotrypsin (100000 AU), a proteolytic enzyme combination used primarily for its anti-inflammatory and fibrinolytic properties. It is indicated in the management of acute and chronic inflammatory conditions, including post-traumatic swelling, surgical edema, and soft tissue injuries. By promoting the breakdown of proteins involved in inflammation and facilitating the removal of necrotic tissue, Kwikheal Tablet aids in reducing edema, pain, and inflammation, thereby accelerating the healing process. The enzymatic action of Trypsin and Chymotrypsin enhances microcirculation and supports the resolution of hematomas and exudates. This medication is commonly prescribed as an adjunct to conventional therapy in conditions such as sprains, strains, contusions, and postoperative inflammation. Kwikheal Tablet should be used under medical supervision, with dosage tailored according to the severity of the condition and patient response. It is contraindicated in individuals with hypersensitivity to proteolytic enzymes, active bleeding disorders, or peptic ulcers. Caution is advised in patients with coagulation abnormalities or those on anticoagulant therapy. Adverse effects are rare but may include gastrointestinal discomfort or allergic reactions. Overall, Kwikheal Tablet is a valuable therapeutic agent in managing inflammatory and edematous conditions to promote faster recovery.